← Back
$BBIO All transactions

BridgeBio Pharma, Inc.

M 10b5-1 Plan

$ Value

$72K

Shares

4,292

Price

$17

Filed

Jun 11

Insider

Name

Valantine Hannah

Title

CIK

0001855608

Roles

Director

Transaction Details

Transaction Date

2025-06-10

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,056

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024. | The stock option vests and becomes exercisable in three annual installments starting on June 22, 2023 and ending on June 22, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors.

Filing Info

Accession No.

0000950170-25-084914

Form Type

4

Issuer CIK

0001743881

Valantine Hannah's History

Date Ticker Type Value
2025-11-12 BBIO M $1.2M
2025-11-12 BBIO $1.7M
2025-11-12 BBIO M $0
2025-06-26 BBIO $39K
2025-06-26 BBIO $68K
2025-06-26 BBIO $18K
2025-06-26 BBIO $83K
2025-06-20 BBIO A $0
2025-06-20 BBIO A $0
2025-06-18 CDNA $203K

Other Insiders at BBIO (90d)

Insider Bought Sold Last
Kumar Neil
Chief Executive Officer
$6.0M 2026-04-10